Equações de referência para o teste de caminhada de seis minutos em indivíduos saudáveis

Dourado, Victor Zuniga

doi:10.1590/s0066-782x2011005000024

Cited by 48 publications

(35 citation statements)

References 42 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Similar results were reported by Soares et al 24 , when they evaluated the applicability of the same equation for Brazilian healthy individuals. As great part of the variability of the observed results, during the application of 6MWT, is due to the population diversity, the use of Brazilian equations 25 are suggested. Therefore, the equation proposed by Iwama et al 19 , verified that the control group walked, on average, 98.55% of the expected D6MWT (p=0.68).…”

Section: Discussionmentioning

confidence: 99%

Redução da capacidade funcional e exacerbação da dor durante o esforço do teste de caminhada de 6 minutos em mulheres com fibromialgia

Homann¹,

Stefanello²,

Góes³

et al. 2011

Rev. bras. fisioter.

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Redução da capacidade funcional e exacerbação da dor durante o esforço do teste de caminhada de 6 minutos em mulheres com fibromialgia

Homann¹,

Stefanello²,

Góes³

et al. 2011

Rev. bras. fisioter.

View full text Add to dashboard Cite

“…Mean exercise intensity (%max HR) varied from 44% to 81% between studies that reported this outcome [191]. Exercise intensity may be influenced by the technician and by the patient's motivation.…”

Section: Exercise Intensitymentioning

confidence: 99%

An official systematic review of the European Respiratory Society/American Thoracic Society: measurement properties of field walking tests in chronic respiratory disease

Singh¹,

Puhan²,

et al. 2014

View full text Add to dashboard Cite

This systematic review examined the measurement properties of the 6-min walk test (6MWT), incremental shuttle walk test (ISWT) and endurance shuttle walk test (ESWT) in adults with chronic respiratory disease.Studies that report the evaluation or use of the 6MWT, ISWT or ESWT were included. We searched electronic databases for studies published between January 2000 and September 2013.The 6-min walking distance (6MWD) is a reliable measure (intra-class correlation coefficients ranged from 0.82 to 0.99 in seven studies). There is a learning effect, with greater distance walked on the second test (pooled mean improvement of 26 m in 13 studies). Reliability was similar for ISWT and ESWT, with a learning effect also evident for ISWT (pooled mean improvement of 20 m in six studies). The 6MWD correlates more strongly with peak work capacity (r50.59-0.93) and physical activity (r50.40-0.85) than with respiratory function (r50.10-0.59). Methodological factors affecting 6MWD include track length, encouragement, supplemental oxygen and walking aids. Supplemental oxygen also affects ISWT and ESWT performance. Responsiveness was moderate to high for all tests, with greater responsiveness to interventions that included exercise training.The findings of this review demonstrate that the 6MWT, ISWT and ESWT are robust tests of functional exercise capacity in adults with chronic respiratory disease. OverviewThe aim of this systematic review was to examine the measurement properties for the 6-min walk test (6MWT), incremental shuttle walk test (ISWT) and endurance shuttle walk test (ESWT) in adults with chronic respiratory disease. A companion paper describes the standard operating procedures for the tests [1]. The key findings of this systematic review are as follows.1) The 6-min walking distance (6MWD) is a valid and reliable measure of exercise capacity for people with chronic lung disease. The 6MWD correlates more strongly with measures of peak work capacity and physical activity than with respiratory function or quality of life, which supports its conceptualisation as a test of functional exercise performance.2) The ISWT offers a different protocol to the 6MWT as it is incremental and externally paced. The ISWT is a valid and reliable measure of cardiopulmonary exercise capacity in chronic obstructive pulmonary disease (COPD), where there is a strong relationship between ISWT distance and peak oxygen uptake (V9O 2 peak) or work rate on a cardiopulmonary exercise test (CPET).3) A learning effect is observed for the 6MWT and the ISWT. The second test usually is the better compared with the first, but this is inconsistent.4) The ESWT is a test of endurance capacity. It is externally paced and is performed along the same course as the ISWT. Two tests do not appear to be necessary if the second test is conducted on the same day.5) Reference equations have been proposed for the 6MWD and the ISWT. Age, height and weight are included in most equations. The influence of race and ethnicity is unclear.6) The safety profile of ...

show abstract

“…There are numerous healthy norms for the 6MWT available and it is unclear which of these would be most appropriate to compare with people with SMA. Moreover, reference equations from various normative data sets for the 6MWT in healthy people have not been compared with 6MWDs in people with SMA, including the normative reference equations most widely used in clinical populations .…”

Section: Introductionmentioning

confidence: 99%

Limitations of 6‐minute walk test reference values for spinal muscular atrophy

et al. 2020

View full text Add to dashboard Cite

Introduction The 6‐minute walk test (6MWT) is a well‐established clinical assessment of functional endurance, validated as a measure of walking ability in spinal muscular atrophy (SMA). The current availability of disease‐modifying therapies for SMA indicates a growing need for normative reference data to compare SMA patients with healthy controls. Methods The literature was searched in two scientific databases. Studies were evaluated and selected based on adherence to American Thoracic Society guidelines for administering the 6MWT. Reference equations from the selected studies were applied to 6MWT data collected from SMA patients to calculate and compare % predicted values. Results Three pediatric and six adult studies were selected for comparison. The % predicted values using the pediatric and adult equations ranged from 47.7 ± 18.2% to 67.6 ± 26.2% and 43.0 ± 17.9% to 59.5 ± 26.2%, respectively, and were significantly different (P < 0.001). Discussion Results suggest significant variability between % predicted values derived from published reference equations in children and adults, despite adherence to 6MWT standardization.

show abstract

Equações de referência para o teste de caminhada de seis minutos em indivíduos saudáveis

Cited by 48 publications

References 42 publications

Redução da capacidade funcional e exacerbação da dor durante o esforço do teste de caminhada de 6 minutos em mulheres com fibromialgia

Redução da capacidade funcional e exacerbação da dor durante o esforço do teste de caminhada de 6 minutos em mulheres com fibromialgia

An official systematic review of the European Respiratory Society/American Thoracic Society: measurement properties of field walking tests in chronic respiratory disease

Limitations of 6‐minute walk test reference values for spinal muscular atrophy

Contact Info

Product

Resources

About